Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)

0.6858
Delayed Data
As of May 22
 -0.0142 / -2.03%
Today’s Change
0.60
Today|||52-Week Range
2.65
-42.85%
Year-to-Date
No recent news for ContraVir Pharmaceuticals Inc.

Today’s Trading

Previous close0.70
Today’s open0.67
Day’s range0.66 - 0.70
Volume480,910
Average volume (3 months)1,019,357
Market cap$53.0M
Dividend yield--
Data as of 3:58pm ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)+38.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OREXOrexigen Therapeutic...-0.12-3.81%
OVASOvaScience Inc-0.03-2.27%
GNMXAevi Genomic Medicin...+0.01+0.77%
ITEKInotek Pharmaceutica...+0.05+2.86%
Data as of 3:59pm ET, 05/22/2017

Financials

Last reporting dateMay 22, 2017
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$0.00
Annual profit (last year)-$17.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
James E. Sapirstein
Chief Financial Officer
John T. Cavan
Corporate headquarters
Edison, New Jersey

Forecasts